WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, February 25, 2004, 24(8):1888-1896; doi:10.1523/JNEUROSCI.3809-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Fig. 1
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (74)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H.-J.
Right arrow Articles by Lee, S.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H.-J.
Right arrow Articles by Lee, S.-J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Degenerative Nerve Diseases
Hazardous Substances DB
*DIMETHYL SULFOXIDE
*ROTENONE

 Previous Article  |  Next Article 

Cellular/Molecular
Clearance of {alpha}-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway

He-Jin Lee, Farnaz Khoshaghideh, Smita Patel, and Seung-Jae Lee

The Parkinson's Institute, Sunnyvale, California 94089

Cytoplasmic deposition of {alpha}-synuclein aggregates is a common pathological feature of many neurodegenerative diseases. Strong evidence for the causative role of {alpha}-synuclein in these disorders is provided by genetic linkage between this gene and familial Parkinson's disease and by neurodegeneration in transgenic animals that overexpress this protein. In particular, it has been hypothesized that the accumulation of nonfibrillar oligomers of {alpha}-synuclein, which serve as intermediates for fibrillar inclusion body formation, causes neurodegeneration. However, little is known about how cells handle potentially toxic protein aggregates. Here we demonstrate that cells are capable of clearing preformed {alpha}-synuclein aggregates via the lysosomal degradation pathway. Consequently, blocking this pathway causes the accumulation of the aggregates in non-neuronal cells, differentiated neuroblastoma cells, and primary cortical neurons. This aggregate clearance occurs in an aggregation stage-specific manner; oligomeric intermediates are susceptible to clearance, whereas mature fibrillar inclusion bodies are not. Neutralization of the acidic compartments leads to the accumulation of {alpha}-synuclein aggregates and exacerbates {alpha}-synuclein toxicity in postmitotic neuronal cells, suggesting that the accumulation of oligomeric intermediates may be an important event leading to {alpha}-synuclein-mediated cell death. These results suggest that enhancing lysosomal function may be a potential therapeutic strategy to halt or even prevent the pathogenesis of Parkinson's disease and other Lewy body diseases.

Key words: {alpha}-synuclein; protein aggregation; lysosome; Parkinson's disease; Lewy body; neurodegeneration

Received Aug 14, 2003; revised December 23, 2003; accepted December 23, 2003.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Desplats, H.-J. Lee, E.-J. Bae, C. Patrick, E. Rockenstein, L. Crews, B. Spencer, E. Masliah, and S.-J. Lee
From the Cover: Inclusion formation and neuronal cell death through neuron-to-neuron transmission of {alpha}-synuclein
PNAS, August 4, 2009; 106(31): 13010 - 13015.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. L. Kragh, L. B. Lund, F. Febbraro, H. D. Hansen, W.-P. Gai, O. El-Agnaf, C. Richter-Landsberg, and P. H. Jensen
{alpha}-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells
J. Biol. Chem., April 10, 2009; 284(15): 10211 - 10222.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Azeredo da Silveira, B. L. Schneider, C. Cifuentes-Diaz, D. Sage, T. Abbas-Terki, T. Iwatsubo, M. Unser, and P. Aebischer
Phosphorylation does not prompt, nor prevent, the formation of {alpha}-synuclein toxic species in a rat model of Parkinson's disease
Hum. Mol. Genet., March 1, 2009; 18(5): 872 - 887.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
T. Pan, S. Kondo, W. Le, and J. Jankovic
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
Brain, August 1, 2008; 131(8): 1969 - 1978.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Hamamichi, R. N. Rivas, A. L. Knight, S. Cao, K. A. Caldwell, and G. A. Caldwell
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
PNAS, January 15, 2008; 105(2): 728 - 733.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto
Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies
J. Biol. Chem., September 28, 2007; 282(39): 28904 - 28914.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Di Fonzo, H. F. Chien, M. Socal, S. Giraudo, C. Tassorelli, G. Iliceto, G. Fabbrini, R. Marconi, E. Fincati, G. Abbruzzese, et al.
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
Neurology, May 8, 2007; 68(19): 1557 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. Klucken, T. F. Outeiro, P. Nguyen, P. J. McLean, and B. T. Hyman
Detection of novel intracellular {alpha}-synuclein oligomeric species by fluorescence lifetime imaging
FASEB J, October 1, 2006; 20(12): 2050 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al.
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
J. Neurosci., April 5, 2006; 26(14): 3685 - 3696.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H.-J. Lee, S. Patel, and S.-J. Lee
Intravesicular Localization and Exocytosis of {alpha}-Synuclein and its Aggregates
J. Neurosci., June 22, 2005; 25(25): 6016 - 6024.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Li, N. West, E. Colla, O. Pletnikova, J. C. Troncoso, L. Marsh, T. M. Dawson, P. Jakala, T. Hartmann, D. L. Price, et al.
Aggregation promoting C-terminal truncation of {alpha}-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
PNAS, February 8, 2005; 102(6): 2162 - 2167.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. M. Cuervo, L. Stefanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer
Impaired Degradation of Mutant {alpha}-Synuclein by Chaperone-Mediated Autophagy
Science, August 27, 2004; 305(5688): 1292 - 1295.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. Li, C. Lesuisse, Y. Xu, J. C. Troncoso, D. L. Price, and M. K. Lee
Stabilization of {alpha}-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation
J. Neurosci., August 18, 2004; 24(33): 7400 - 7409.
[Abstract] [Full Text] [PDF]


-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-